Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

Contact Us

Search

Neuroscience News

Neuroscience News with Expert Insights and Video Summaries

Neuroscience

Neuroscience Weekly News - April 16th 2025

Next-Level Neuroscience Innovations Unveiled 🧠 In this week’s Neuroscience…

Neuroscience

Neuroscience Weekly News - April 9th 2025

🧠 This Week in Neuroscience: Game-Changing Advances You Need to Know! In this…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission
Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration
Public Health Video Recap—January 30, 2026
Public Health Today—30 January, 2026

Tags

Abeona advanced therapies alcohol carcinogenicity bioinformatics Biologic respiratory drugs cancer Cardiovascular drug pipeline Cellenkos Charcot Marie Tooth disease type 2S Citizen Health ckd corporate venture capital Curadel drug pricing drug supply chain Elranatamab Epidemiology insights ESMO 2021 FDA obesity approvals FDA women’s health approvals gene editing gene therapy approval Grifols Egypt hematology HER2-positive metastatic breast cancer investment lab automation licensing deal nanotechnology NFTs in healthcare non viral vectors oncology trials Parainfluenza Virus Type 3 Perioperative immunotherapy pharma regulatory pathway remote patient monitoring Secura Bio Sema4 T-cell leukemia Teizeild tissue engineering unconventional trial designs wildfire smoke Zavabresib

Archives

Archives

1
…
3
4
5

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission
Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration
Public Health Video Recap—January 30, 2026
Public Health Today—30 January, 2026

TAGS

Abeona advanced therapies alcohol carcinogenicity bioinformatics Biologic respiratory drugs cancer Cardiovascular drug pipeline Cellenkos Charcot Marie Tooth disease type 2S Citizen Health ckd corporate venture capital Curadel drug pricing drug supply chain Elranatamab Epidemiology insights ESMO 2021 FDA obesity approvals FDA women’s health approvals gene editing gene therapy approval Grifols Egypt hematology HER2-positive metastatic breast cancer investment lab automation licensing deal nanotechnology NFTs in healthcare non viral vectors oncology trials Parainfluenza Virus Type 3 Perioperative immunotherapy pharma regulatory pathway remote patient monitoring Secura Bio Sema4 T-cell leukemia Teizeild tissue engineering unconventional trial designs wildfire smoke Zavabresib

Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy